Increased urinary TGF-β1 and cortical renal GLUT1 and GLUT2 levels: Additive effects of hypertension and diabetes

Nephron - Physiology

Volumn 100, Issue 3, 2005, Pages

  Schaan, Beatriz D'Agord ^a,e   Irigoyen, Maria Cláudia ^b   Bertoluci, Marcello C ^c,d   De Lima, Nelson Gianni ^a   Passaglia, Juliana ^a   Hermes, Eduardo ^a   Oliveira, Fabio Ramos ^d   Okamoto, Maristela ^b   Machado, Ubiratan Fabres ^b  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e Unidade de Pesquisa   (Brazil)

Author keywords

Albuminuria; Diabetic nephropathy; Glucose transporters; Streptozotocin induced diabetes; Transforming growth factor beta 1

Indexed keywords

ALBUMIN; BUFFER; CITRIC ACID; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CATHETER; CONTROLLED STUDY; DIABETES MELLITUS; FEMORAL ARTERY; HYPERGLYCEMIA; HYPERTENSION; KIDNEY CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; SPINAL CORD COMPRESSION; SPONTANEOUSLY HYPERTENSIVE RAT; URINALYSIS; WESTERN BLOTTING;

EID: 20844431707     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085413     Document Type: Article

References (46)

1. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA: Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) 1987;294:1443-1447.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
3. UK Prospective Diabetes Study (UKPDS) Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 1998;317:703-713.
4. Cooper ME: Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 2001;44:1957-1972.
5. Bertoluci MC, Schmid H, Lachat JJ, Coimbra TM: Transforming growth factor-beta in the development of rat diabetic nephropathy: A 10-month study with insulin-treated rats. Nephron 1996;74:189-196.
6. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H: Increased renal GLUT1 abundance and urinary TGF-β1 in streptozotocin-induced diabetic rats: Implications for the development of nephropathy complicating diabetes. Horm Metab Res 2001;33:664-669.
7. D'Agord Schaan B, Lacchini S, Bertoluci MC, Irigoyen MC, Machado UF, Schmid H: Impact of renal denervation on renal content of GLUT1, albuminuria, and urinary TGF-β1 in streptozotocin-induced diabetic rats. Auton Neurosci 2003;104:88-94.
8. Dominguez JH, Camp K, Maianu L, Feister H, Garvey WT: Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. Am J Physiol 1994;266(2 Pt 2): F283-F290.
9. D'Agord Schaan B, Lacchini S, Schmid H, Irigoyen MC, Okamoto MM, Machado UF: Modulation of facilitative glucose transporters in diabetes and renal denervation (poster 1805). 18th Int Diabetes Federation Congr, Paris 2003.
10. Zhang J, Liu Z, Liu D, Li L: Identification of glucose transporter-1 and its functional assay in mouse glomerular mesangial cells cultured in vitro. Chin Med Sci J 2001;16:35-39.
11. Li Y, Liu Z, Liu D, Zhang J, Chen Z, Li L: Identification and function of glucose transporter 1 in human mesangial cells. Chin Med J (Engl) 2001;114:824-828.
12. Heilig CW, Concepcion LA, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose millieu mimics the diabetic phenotype. J Clin Invest 1995;96:1802-1814.
13. Zhu J, Liu Z, Li Y: Inhibition of glucose transporter 1 overexpression in mesangial cells by rhein (in Chinese). Zhonghua Nei Ke Za Zhi 2001;40:537-542.
14. Cortes P, Zhao X, Riser BL, Narins RG: Role of glomerular mechanical strain in the pathogenesis of diabetic nephropathy. Kidney Int 1997;51:57-68.
15. Hirakata M, Kaname S, Chung UG, Joki N, Hori Y, Noda M, Takuwa Y, Okazaki T, Fujita T, Katoh T, Kurokawa K: Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney Int 1997;51:1028-1036.
16. Schaan BD, Maeda CY, Timm HB, Medeiros S, Moraes RS, Ferlin E, Fernandes TG, Ribeiro JP, Schmid H, Irigoyen MC: Time course of changes in heart rate and blood pressure variability in streptozotocin-induced diabetic rats treated with insulin. Braz J Med Biol Res 1997; 30:1081-1086.
17. Cooper ME, Allen TJ, Macmillan P, Bach L, Jerums G, Doyle AE: Genetic hypertension accelerates nephropathy in the streptozotocin diabetic rat. Am J Hypertens 1988;1:5-10.
18. Righetti AE, Boer-Lima PA, Lopes de Faria JB: The presence of genetic hypertension stimulates early renal accumulation of fibronectin in experimental diabetes mellitus. Diabetologia 2001;44:2088-2091.
19. Nose A, Mori Y, Uchiyama-Tanaka Y, Kishimoto N, Mamyama K, Matsubara H, Iwasaka T: Regulation of glucose transporter (GLUT1) gene expression by angiotensin II in mesangial cells: Involvement of HB-EGF and EGF receptor transactivation. Hypertens Res 2003;26:67-73.
20. Gnudi L, Viberti G, Raij L, Rodriguez V, Burt D, Cortes P, Hartley B, Thomas S, Maestrini S, Gruden G: GLUT-1 overexpression: Link between hemodynamic and metabolic factors in glomerular injury? Hypertension 2003;42:19-24.
21. Arendshorst WJ, Beierwaltes WH: Renal and nephron hemodynamics in spontaneously hypertensive rats. Am J Physiol 1979;236:F246-F251.
22. Vestri S, Okamoto MM, de Freitas HS, Aparecida Dos Santos R, Nunes MT, Morimatsu M, Heimann JC, Machado UF: Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol 2001;182:105-112.
23. Vestri S, Nikami M, Saito M, Machado UF: Production of antisera to synthetic decapeptide of the COOH-terminus of rat GLUT2. Braz Arch Biol Technol 1998;41:194-198.
24. Tolbert EM, Weisstuch J, Feiner HD, Dworkin LD: Onset of glomerular hypertension with aging precedes injury in the spontaneously hypertensive rat. Am J Physiol Renal Physiol 2000;278:F839-F846.
25. Zatz R, Meyer TW, Rennke HG, Brenner BM: Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985;82:5963-5967.
26. Obata J, Nakamura T, Takano H, Naito A, Kimura H, Yoshida Y, Shimizu F, Guo DF, Inagami T: Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats. J Hypertens 2000;18:1247-1255.
27. Quinn LA, McCumbee WD: Regulation of glucose transport by angiotensin II and glucose in cultured vascular smooth muscle cells. J Cell Physiol 1998;177:94-102.
28. Winternitz SR, Katholi RE, Oparil S: Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest 1980;66:971-978.
29. Noonan WT, Shapiro VM, Banks RO: Renal glucose reabsorption during hypertonic glucose infusion in female streptozotocin-induced diabetic rats. Life Sci 2001;68:2967-2977.
30. Marks J, Carvou NJ, Debnam ES, Srai SK, Unwin RJ: Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane. J Physiol 2003;553(Pt 1):137-145.
31. Gaede P, Vedel P, Parving HH, Pedersen O: Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study. Lancet 1999;353:617-622.
32. Waeber G, Thompson N, Nicod P, Bonny C: Transcriptional activation of the GLUT2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 1996;10:1327-1334.
33. Kim JW, Ahn YH: CCAAT/enhancer binding protein regulates the promoter activity of the rat GLUT2 glucose transporter gene in liver cells. Biochem J 1998;336(Pt 1):83-90.
34. Kim HI, Kim JW, Kim SH, Cha JY, Kim KS, Ahn YH: Identification and functional characterization of the peroxisomal proliferator response element in rat GLUT2 promoter. Diabetes 2000;49:1517-1524.
35. Cha JY, Kim H, Kim KS, Hur MW, Ahn Y: Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene: Cooperative role of hepatocyte nuclear factors 1 alpha and 3 beta. J Biol Chem 2000;275:18358-18365.
36. Wang X, Zhou J, Doyle ME, Egan JM: Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. Endocrinology 2001;142:1820-1827.
37. Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A: Regulation of glut1 mRNA by hypoxia-inducible factor-1: Interaction between H-ras and hypoxia. J Biol Chem 2001;276:9519-9525.
38. Kainer DB, Doris PA: Cyclophilin B expression in renal proximal tubules of hypertensive rats. Hypertension 2000;35:958-964.
39. Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R: TGF-β1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 1999;55:1704-1712.
40. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius FC 3rd: D-Glucose stimulates mesangial cell GLUT1 expression and basal and IGF-I-sensitive glucose uptake in rat mesangial cells: Implications for diabetic nephropathy. Diabetes 1997;46:1030-1039.
41. Gruden G, Zonca S, Hayward A, Thomas S, Maestrini S, Gnudi L, Viberti G: Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent. Diabetes 2000;49:655-661.
42. Singh R, Alavi N, Singh AK, Leehey DJ: Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation. Diabetes 1999;48:2066-2073.
43. Leehey DJ, Singh AK, Alavi N, Singh R: Role of angiotensin II in diabetic nephropathy. Kidney Int Suppl 2000;77:S93-S98.
44. Hovind P, Rossing P, Tarnow L, Smidt UM, Parving HH: Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int 2001;60:277-283.
45. Cooper ME, Allen TJ, O'Brien RC, Macmillan PA, Clarke B, Jerums G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat - functional and structural characteristics. J Hypertens 1988;6:1009-1016.
46. Asada T, Ogawa T, Iwai M, Shimomura K, Kobayashi M: Recombinant insulin-like growth factor I normalizes expression of renal glucose transporters in diabetic rats. Am J Physiol 1997;273(1 Pt 2):F27-F37.